Postoperative Follow-Up and Complications

  • Antonio Pacifico
  • Philip D. Henry
Part of the Developments in Cardiovascular Medicine book series (DICM, volume 244)


This chapter discusses the postoperative follow-up and surgical complications after ICD implantation. Postoperative electrophysiologic testing is covered in the previous chapter and general complications of ICD therapy are addressed in the chapters entitled “ICD Lead System Dysfunction, Diagnosis and Therapy” and “Rhythm-related Complications and Adverse Events in Patients with Implantable Cardioverter-Defibrillators”.


Pulmonary Embolism Pacemaker Implantation Permanent Pacemaker Freeze Shoulder Deep Sternal Wound Infection 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Gupta A, Zegel HE, Dravis VS, Nierenberg SJ,Freiman DB. Value of radiography in diagnosing complications of cardioverter-defibrillators implanted without thoracotomy. AJR Am J Roentgenol 1997;168:105–108PubMedGoogle Scholar
  2. 2.
    Korte T, Jung W, Schlippert U, Wolpert C, Esmailzadeh B, Fimmers R, Schmitt O, Luderitz B. Prospective evaluation of shoulder-related problems in patients with pectoral cardioverter-defibrillator implantation. Am Heart J 1998;135:577–583PubMedCrossRefGoogle Scholar
  3. 3.
    Burke MC, Drinan K, Kopp DE, Kall JG, Verdino RG, Paydak H, Wilber DJ. Frozen shoulder syndrome associated with subpectoral defibrillator implantation. J Intery Card Electrophysiol 1999;3:253–256CrossRefGoogle Scholar
  4. 4.
    Jones GK, Bardy GH, Kudenchuk PJ, Poole JE, Dolack GL, Troutman C, Anderson J, Johnson J. Mechanical complications after implantation of multi-lead nonthoracotomy defibrillator systems: implications for management and future system design. Am Heart J 1995;327–333Google Scholar
  5. 5.
    Pacifico A, Wheelan KR, Nasir N, Jr, Wells PJ, Doyle TK, Johnson SA, Henry PD. Long-term follow-up f cardioverter-defibrillator implanted under conscious sedation in prepectoral sufascial position. Circulation 1997;95:946–950PubMedCrossRefGoogle Scholar
  6. 6.
    Gold MR, Peters RW, Johnson JW, Shorofsky SR. Complications associated with pectoral implantation of cardioverter-defibrillators. Worldwide Jewel Investigators. PACE 1997;20:208–211PubMedCrossRefGoogle Scholar
  7. 7.
    Pacifico A, Johnson JW, Stanton MS, Steinhaus DM, Gabler R, Church T, Henry PD. Comparison of results in two implantable defibrillators. Am J Cardiol 1998;82:875–880PubMedCrossRefGoogle Scholar
  8. 8.
    Grimm W, Menz, Hoffmann J, Timmann U, Funk R, Moosdorf R, Maisch B. Complications of third-generation implantable cardioverter-defibrillator therapy. PACE 1999;22:206–211PubMedCrossRefGoogle Scholar
  9. 9.
    Shahian DM, Venditti FJ. Hemothorax associated with anticoagulation after placement of implantable cardiovcrter defibrillator: possible similarity to postinfarction Dressler’s syndrome. PACE 1992;15:1233–1235PubMedCrossRefGoogle Scholar
  10. 10.
    Spittell PC, Hayes DL. Venous complications after insertion of a transvenous pacemaker. Mayo Clin Proc 1992;67:258–265PubMedGoogle Scholar
  11. 11.
    Mitrovic C, Thormann J, Schlepper M, Neuss H. Thrombotic complications with pacemakers. Int J Cardiol 1983;2:363–374PubMedCrossRefGoogle Scholar
  12. 12.
    Lin LJ, Lin JL, Tsai WC, Teng JK, Tsai LM, Chen JH. Venous access thrombosis detected by transcutaneous vascular ultrasound in patients with single polyurethane-lead permanent pacemaker. PACE 1998;21:396–400PubMedCrossRefGoogle Scholar
  13. 13.
    De Cock CC, Vinkers M, Van Campe LC, Verhorst PM, Visser CA. Long-term outcome of patients with multiple (> or = 3) noninfected transvenous leads: a clinical and echocardiographic study. PACE 2000;23:423–426PubMedCrossRefGoogle Scholar
  14. 14.
    Schwartzbard AZ, Tunick PA, Rosenzweig BP, Krozon I. The role of transesophageal echocardiography in the diagnosis and treatment of right atrial thrombi. J Am Soc Echocardiogr 1999;12:64–69PubMedCrossRefGoogle Scholar
  15. 15.
    Barakat K, Robinson NM, Spurrelll RA. Transvenous pacing lead-induced thrombosis:a series of cases with a review of the literature. Cardiology 2000;93:142–148PubMedCrossRefGoogle Scholar
  16. 16.
    Trigano JA, Paganelli F, Ricard P, Ferracci A, Avierinos JF, Levy S. Heart perforation following transvenous implantation of cardiac pacemakers. Presse Med 1999;28:836–840PubMedGoogle Scholar
  17. 17.
    Tsang TS, Freeman WK, Barnes ME, Reeder GS, Packer DL, Seward JB. Rescue echocardiographically guided pericardiocentesis for cardiac perforation complicating catheter-based procedures. The Mayo Clinic experience. J Am Coll Cardiol 1998;32:1345–1350PubMedCrossRefGoogle Scholar
  18. 18.
    Trappe HJ, Pfitzner P, Klein H, Wenzlaff P. Infections after cardioverter-defibrillator implantation: observations in 335 patients over 10 years. Br Heart J 1995;73:20–24PubMedCrossRefGoogle Scholar
  19. 19.
    O’Nunain S, Perez I, Roelke M, Osswald S, McGovern BA, Brooks DR, Torchiana DF, Vlahakes GJ, Ruskin J, Garan H. The treatment of patients with infected implantable cardioverter-defibrillator systems. J Thorac Cardiovasc Surg 1997;113::121–129PubMedCrossRefGoogle Scholar
  20. 20.
    Smith PN, Vidaillet HJ, Hayes JJ, Wethington PJ, Stahl L, Hull M, Broste SK. Infections with nonthoracotomy implantable cardioverter-defibrillators: can these be prevented? Endotak Lead Clinicial Investigators. PACE 1998;21:42–55PubMedCrossRefGoogle Scholar
  21. 21.
    Samuels LE, Samuals FL, Kaufman MS, Morris RJ, Brockman SK. Management of infected implantable cardiac defibrillators. Ann Thorac Surg 1997;64:1702–1706PubMedCrossRefGoogle Scholar
  22. 22.
    Lee JH, Geha AS, Rattehalli NM, Cmolik BL, Johnson NJ, Biblo LA, Carlson MD, Waldo AL. Salvage of infected ICDs: management without removal. PACE 1996;19:437–442PubMedCrossRefGoogle Scholar
  23. 23.
    Vogt PR, Sagdic K, Lachat M, Candinas R, von Segesser LK, Turina MI. Surgical management of infected permanent transvenous pacemaker systems: ten year experience. J Card Surg 1996;11:180–186PubMedCrossRefGoogle Scholar
  24. 24.
    Aggarwal RK, Connely DT, Ray SG, Ball G, Charles RG. Early complications of permanent pacemaker implantation: no difference between dual and single chamber systems. Br Heart J 1995;73:571–575PubMedCrossRefGoogle Scholar
  25. 25.
    Chauhan A, Grace AA, Newell SA, Stone DL, Shapiro LM, Schofield PM, Petch MC. Early complications after dual versus single chamber pacemaker implantation. PACE 1994;17:2012–2015PubMedCrossRefGoogle Scholar
  26. 26.
    Tighe DA, Tejada LA, Kirchhoffer JB, Gilmette P, Rifkin RD, Estes NA. Pacemaker lead infection: detection by multiplane transesophageal echocardiography. Am Heart J 1996;131:616–618PubMedCrossRefGoogle Scholar
  27. 27.
    Voet JG, Vandekerckhove YR, Muyldermans LL, Missault LH, Matthys LG. Pacemaker lead infection: report of three cases and review of the literature. Heart 1999;81:88–91PubMedGoogle Scholar
  28. 28.
    Vilacosta I, Sarnia C, San Roman JA, Jimenez J, Castillo JA, Iturralde E, Rollan MJ, Martinez Elbal L. Usefulness of transesophageal echocardiography for diagnosis of infected transvenous permanent pacemakers. Circulation 1994;89:2684–2687PubMedCrossRefGoogle Scholar
  29. 29.
    Klug D, Lacroix D, Goullard L, Grandmougin D, Hennquin JL, Kacet S, Lekieffre J. Systemic infection related to endocarditis on pacemaker leads: clinical presentation and management. Circulation 1997;95:2098–2107PubMedCrossRefGoogle Scholar
  30. 30.
    Laguno M, Miro O, Font C, dela Sierra A. Pacemaker-related endocarditis. Report of 7 cases and review of the literature. Cardiology 1998;90:244–248PubMedCrossRefGoogle Scholar
  31. 31.
    Da Costa A, Kirkorian G, Isaaz K, Touboul P. Secondary infections after pacemaker implantation. Rev Med Int 2000;21:256–265CrossRefGoogle Scholar
  32. 32.
    Molina JE. Undertreatment and overtreatment of patients with infected antiarrhythmic implantable devices. Ann Thorac Surg 1997;63:504–509PubMedCrossRefGoogle Scholar
  33. 33.
    Byrd CL. Management of implant complications. In: Ellenbogen KA, Kay GN, Wilkoff BL, eds. Clinical Cardiac Pacing and Defibrillation, 2nd edition. WB Saunders Co, Philadelphia, 2000:669–694Google Scholar
  34. 34.
    Turkisher V, Priel I, Dan M. Successful management of an infected implantable cardioverter-defibrillator with oral antibiotics and without removal of the device. PACE 1997;20:2268–2270PubMedCrossRefGoogle Scholar
  35. 35.
    Taylor RL, Cohen DG, Widman LE, Chilton RJ, O’Rourke RA. Infection of an implantable cardioverter-defibrillator: management without removal of the device in selected cases. PACE 1990;13:1352–1355PubMedCrossRefGoogle Scholar
  36. 36.
    Ryu JH, Olson EJ, Pellika PA. Clinical recognition of pulmonary embolism: problem of unrecognized and asymptomatic cases. Mayo Clin Proc 1998;73:873–879PubMedCrossRefGoogle Scholar
  37. 37.
    Lensing AWA, Prandoni P, Prins MH, Buller HR. Deep-vein thrombosis. Lancet 1999;353:479–485PubMedCrossRefGoogle Scholar
  38. 38.
    Porter KA, O’Conner S, Rimm E, Lopez M. Electrocautery as a factor in seroma formation following mastectomy. Am J Surg 1998;176:8–11PubMedCrossRefGoogle Scholar
  39. 39.
    Schultz I, Barholm M, Grondal S. Dalayed shoulder exercise in reducing seroma formation after modified radical mastectomy: a prospective randomized study. Ann Surg Oncol 1997;4:293–297PubMedCrossRefGoogle Scholar
  40. 40.
    Trick WE, Scheckler WE, Tokars JI, Jones KC, Reppen MI, Smith EM, Jarvis WR. Modifiable risk factors associated with deep sternal site infection after coronary artery surgery. J Thorac Cardiovasc Surg 2000;119:108–114PubMedCrossRefGoogle Scholar
  41. 41.
    Spelman DW, Russo P, Harrington G, Davis BB, Rabinov M, Smith JA, Spicer WJ, Esmore D. Risk factors for surgical wound infection and bacteraemia following coronary artery bypass surgery. Aus N Z J Surg 2000;70:47–51CrossRefGoogle Scholar
  42. 42.
    Furnary AP, Zerr KJ, Grunkemeier GL, Starr A. Continuous intravenous insulin infusion reduces the incidence of deep sternal wound infection in diabetic patients after cardiac surgical procedures. Am Thorac Surg 1999;67:352–360CrossRefGoogle Scholar
  43. 43.
    Rassias AJ, Marrin CA, Arruda J, Whalen PK, Beach M, Yeager MP. Insulin infusion improves neutrophil function in diabetic cardiac surgery patients. Anesth Analg 1999;88:1011–1016PubMedGoogle Scholar
  44. 44.
    McCowen KC, Malhotra A, Bistrian BR. Stress-induced hyperglycemia. Crit Care 2001:17:107–124Google Scholar
  45. 45.
    Cierpka R, Trappe HJ, Pfitzner P, Lichtlen PR. “Circumscribed defibrillator erythema”: a differential diagnostic and therapeutic problem in occult defibrillator infection diagnosis. Z Kardiol 1996;85:312–318PubMedGoogle Scholar
  46. 46.
    Walenkamp GH, Kleijn LL, de Leeuw M. Osteomyelitis treated with gentamycinPMMA beads: 100 patients followed for 1–12 years. Acta Orthop Scand 1998;69:518–522PubMedCrossRefGoogle Scholar
  47. 47.
    Calhoun JH, Mader JT. Treatment of osteomyelitis with biodegradable antibiotic implant. Clin Orthop 1997;341:206–214PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2002

Authors and Affiliations

  • Antonio Pacifico
    • 1
  • Philip D. Henry
    • 1
  1. 1.Texas Arrhythmia InstituteHoustonUSA

Personalised recommendations